Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Doc Bones who wrote (7265)	10/29/2002 9:20:19 AM
From: Biomaven	Read Replies (4) \| Respond to of 52153

"obtained information from a questionable source about a patient who could not be roused after taking the medication being tested on behalf of Neurocrine," the NASD said. Well it would be nice if the article had mentioned that the patient had apparently taken narcotics... My concern here is that this article doesn't present clearly enough that the information in the report was just plain wrong. It makes Stirling sound more aggressive than criminal. Peter